Share

April 2015; 5 (2) Eye on Practice

The demise of direct ophthalmoscopy

A modern clinical challenge

Devin D. Mackay, Philip S. Garza, Beau B. Bruce, Nancy J. Newman, Valérie Biousse
First published December 29, 2014, DOI: https://doi.org/10.1212/CPJ.0000000000000115
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1167

Share

Article Information

vol. 5 no. 2 150-157
DOI: 
https://doi.org/10.1212/CPJ.0000000000000115
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published December 29, 2014.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Devin D. Mackay, MD,
    2. Philip S. Garza, BS,
    3. Beau B. Bruce, MD, MS,
    4. Nancy J. Newman, MD and
    5. Valérie Biousse, MD
  1. Devin D. Mackay, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Philip S. Garza, BS,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Beau B. Bruce, MD, MS,
    4. Scientific Advisory Boards:

    1. MedImmune

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Kaiser Permanente of Georgia for the CDC Vaccine Safety Datalink

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Teva pharmaceuticals, Pfizer, Novartis

    Research Support, Government Entities:

    1. NIH/PHS Grants UL1-RR025008 & KL2-RR025009 2008-2009 NIH/PHS Grant K23-EY019341 2009-present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Was a Recipient of the AAN/AAN Foundation Practice Research Fellowship

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Nancy J. Newman, MD and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Journal of Neuro-Ophthalmology, editorial advisory board, > 5 years (2) American Journal of Ophthalmology, executive editor, > 5 years

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Neuro-Ophthalmology Illustrated, Thieme, 2009 (2) Walsh & Hoyt's Clinical Neuro-Ophthalmology The Essentials, 1st and 2nd editions, Lippincott Williams and Wilkins, 1999, 2008 (3) Walsh & Hoyt's Clinical Neuro-Ophthalmology, Lippincott Williams and Wilkins, 5th and 6th editions, 1998, 2005 (4) Blue Books of Neurology: Neuro-Ophthalmology, Butterworth Heinemann Elsevier, 2008

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Trius Pharma -- consultant Gensight -- consultant

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Research to Prevent Blindness, New York, N.Y., unrestricted departmental grant, Lew R. Wasserman Merit Award, > 5 years

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. has provided expert testimony on multiple topics in multiple medical legal settings

  5. Valérie Biousse, MD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial boards of: American Journal of Ophthalmology Journal of Neuro-ophthalmology

    Patents:

    1. NONE

    Publishing Royalties:

    1. Walsh and Hoyt's Clinical Neuro-Ophthalmology. Williams and Wilkins Neuro-Ophthalmology Illustrated. Thieme NY Up-to-date

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Gensight. Consultant

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Research to Prevent Blindness

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Departments of Neurology, Ophthalmology, and Neurosurgery (DDM), Indiana University School of Medicine, Indianapolis, IN. Departments of Ophthalmology (PSG, BBB, NJN, VB), Neurology (BBB, NJN, VB), and Neurological Surgery (NJN), Emory University School of Medicine; and Department of Epidemiology (BBB), Rollins School of Public Health and Laney Graduate School, Emory University, Atlanta, GA.
  1. Correspondence to:
    vbiouss{at}emory.edu
View Full Text

Article usage

Article usage: December 2014 to October 2021

AbstractFullPdfSource
Dec 20142002Highwire
Jan 2015482021Highwire
Feb 201511205Highwire
Mar 20157106Highwire
Apr 20157222971Highwire
May 20152701310Highwire
Jun 201524338Highwire
Jul 201511344Highwire
Aug 20155801Highwire
Sep 20158205Highwire
Oct 20153801Highwire
Nov 20154314Highwire
Dec 20155902Highwire
Jan 20165803Highwire
Feb 20163010Highwire
Mar 20164102Highwire
Apr 20162710Highwire
Apr 20160159pmc
May 20163901Highwire
May 20160264pmc
Jun 20163511Highwire
Jun 2016085pmc
Jul 20163703Highwire
Jul 20160185pmc
Aug 20167401Highwire
Aug 20160489pmc
Sep 20169310Highwire
Sep 201604514pmc
Oct 20166203Highwire
Oct 201606812pmc
Nov 20165701Highwire
Nov 201603612pmc
Dec 20164201Highwire
Dec 20160387pmc
Jan 20174500Highwire
Jan 201705910pmc
Feb 20173700Highwire
Feb 20170307pmc
Mar 20174601Highwire
Mar 20170413pmc
Apr 20175110Highwire
Apr 2017144658pmc
May 20173100Highwire
May 201795362pmc
Jun 20174101Highwire
Jun 2017133231pmc
Jul 20173300Highwire
Jul 201734751pmc
Aug 20171401Highwire
Aug 201785361pmc
Sep 20171802Highwire
Sep 201786674pmc
Oct 20173500Highwire
Oct 201775272pmc
Nov 20172001Highwire
Nov 201785985pmc
Dec 20174061Highwire
Jan 20189020Highwire
Feb 20184553Highwire
Mar 20184932Highwire
Apr 20187070Highwire
Apr 2018680134pmc
May 20186932Highwire
Jun 20185200Highwire
Jun 201813111130pmc
Jul 20185110Highwire
Aug 20185520Highwire
Aug 2018107683pmc
Sep 20188002Highwire
Oct 20187140Highwire
Nov 20185411Highwire
Dec 201813000Highwire
Jan 201914200Highwire
Feb 201922543Highwire
Mar 201910956Highwire
Apr 20197020Highwire
May 20198240Highwire
Jun 20196266Highwire
Jul 20194921Highwire
Aug 20193333Highwire
Sep 20197040Highwire
Oct 201998222Highwire
Nov 20196874Highwire
Dec 20198922Highwire
Jan 20207044Highwire
Feb 20204463Highwire
Mar 20204685Highwire
Apr 20203732Highwire
May 20203712Highwire
Jun 20202561Highwire
Jul 20202920Highwire
Aug 20201300Highwire
Sep 20204731Highwire
Oct 20206232Highwire
Nov 20208321Highwire
Dec 20207920Highwire
Jan 20214550Highwire
Feb 20216540Highwire
Mar 20216351Highwire
Apr 202110022Highwire
May 20218131Highwire
Jun 20216320Highwire
Jul 20214532Highwire
Aug 20217871Highwire
Sep 20216051Highwire
Oct 20218020Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me